Use in adolescents and children
The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years or older is 3 mg once a day taken in the morning.
For adolescents weighing 51 kg or more, the dose can be increased within the interval of 6 mg to 12 mg once a day.
For adolescents weighing less than 51 kg, the dose can be increased to 6 mg once a day.
Your doctor will decide how much to administer to you. The amount you take depends on how well the medication works for you.
How and when to take paliperidone
This medication should be taken by mouth, swallowed whole with water or other liquids. It should not be chewed, broken, or crushed.
This medication should be taken in the mornings with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication with breakfast and on an empty stomach the next day.
The active ingredient, paliperidone, dissolves once swallowed, and the coating of the tablet is eliminated from the body by the kidneys.
Patients with kidney problems
Your doctor may adjust your dose of this medication according to your kidney function.
Patients of advanced age
Your doctor may reduce your medication dose if your kidney function is reduced.
If you take more paliperidone than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicological Information Service. Phone: 91 562 04 20 indicating the medication and the amount ingested. You may experience drowsiness, confusion, abnormal body movements, difficulty staying upright and walking, dizziness due to reduced blood pressure, and alterations in heartbeats.
If you forgot to take paliperidone
Do not take a double dose to compensate for the missed doses. If you forget a dose, take the next dose the next day. If you forget two or more doses, contact your doctor.
If you interrupt the treatment with paliperidone
Do not stop taking this medication as you will lose the effects of the medication. Do not stop taking this medication unless your doctor tells you to, as the symptoms may reappear.
If you have any other doubts about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, althoughnotall people experience them.
Inform your doctor immediately if you experience any of the following:
•you develop blood clots in your veins, especially in your legs (symptoms include swelling, pain, and redness of the leg), which can travel through the blood vessels to your lungs, causing chest pain and difficulty breathing. If you notice any of these symptoms, seek medical adviceimmediately.
•you have dementia and experience a sudden change in your mental state or sudden weaknessornumbness in your face, arms, or legs, especially on one side, or difficulty speaking even for a short period of time. These may be signs of a heart attackcerebral.
•you develop fever, muscle stiffness, sweating, or a decrease in your level ofconsciousness(a condition known as “Neuroleptic Malignant Syndrome”). You may needtreatmentmedical
•you are a man and experience a prolonged or painful erection. This is known as priapism.You may need medicaltreatment
•you experience involuntary rhythmic movements of your tongue, mouth, and face. You may need toretirepaliperidona
•you experience a severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, hives, skin rash, and sometimes a decrease in blood pressure (i.e., anaphylacticreaction).
Very common (may affect more than 1 in 10patients)
Common side effects (may affect up to 1 in 10patients)
Rare side effects (may affect up to 1 in 100patients)
Rare side effects (may affect up to 1 in 1,000patients)
Unknown (frequency cannot be estimated from availabledata)
The following side effects have been reported with the use of another medicine calledrisperidonathat is very similar to paliperidone, so it is also expected to occur with paliperidone:othertypes of blood vessel problems in the brain, crepitant sounds of the lungs, and severe or potentially fatal skin rash with blisters and peeling of the skin that may start in the mouth, nose, eyes, and genitals and spread to other areas of the body (Stevens-Johnson syndrome/toxic epidermal necrolysis).Eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken thismedicament
Additional side effects inadolescents
Adolescents generally experienced side effects similar to those found in adults, except for the following side effects that were detected morefrequently:
Reporting of side effects
If you experience side effects, consult your doctor, pharmacist, or nurse, even if the side effects do not appear in this leaflet. You can also report them directlyatravésoftheSistema Español de Farmacovigilancia de Medicamentos de Uso Humano:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of thismedicament
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD or EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
This medication does not require special temperature conditions for its conservation.
Medicines should not be thrown down the drains or in the trash. Dispose of the containers and medicines you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Paliperidone ratiopharm
Appearance of the product and contents of the packaging
3 mg: Film-coated, round, biconvex, white to off-white tablets with possible uneven surface and printed with the mark P3 on one side of the tablet. Diameter: approximately 9 mm.
6 mg: Film-coated, round, biconvex, yellowish-brown tablets with possible uneven surface and printed with the mark P6 on one side of the tablet. Diameter: approximately 9 mm.
9 mg: Film-coated, round, biconvex, pale pink tablets with possible uneven surface and printed with the mark P9 on one side of the tablet. Diameter: approximately 9 mm.
Paliperidone ratiopharm is available in boxes containing:
Not all packaging sizes may be marketed.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
ratiopharm España, S.A.
c/ Anabel Segura, 11, Edificio Albatros B, 1st floor,
Alcobendas, 28108 Madrid (Spain)
Responsible manufacturer:
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501
Slovenia
Last revision date of thisleaflet:November 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.